Drug-induced esophagitis

Diseases of the Esophagus

Volumn 22, Issue 8, 2009, Pages 633-637

  Zografos, G N ^a   Georgiadou, D ^a   Thomas, D ^a,b   Kaltsas, G ^b   Digalakis, M ^c  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Department of Surgery   (Greece)

Author keywords

Drugs; Esophageal injury; Esophagitis

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; EMEPRONIUM; NONSTEROID ANTIINFLAMMATORY AGENT;

CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ESOPHAGITIS; ESOPHAGUS; HUMAN; MUCOSA; PATHOLOGY; PROGNOSIS; REVIEW;

ALENDRONATE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE DENSITY CONSERVATION AGENTS; EMEPRONIUM; ESOPHAGITIS; ESOPHAGUS; HUMANS; MUCOUS MEMBRANE; PARASYMPATHOLYTICS; PROGNOSIS;

EID: 77649290357     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.00972.x     Document Type: Review

References (48)

1. Kikendall J W, Arnold G F, Oyewole M A, Fleischer D, Johnson L F. Pill-induced esophageal injury. Case reports and review of the medical literature. Dig Dis Sci 1983; 28: 174-82.
2. Bott S, Prakash C, McCallum R W. Medication-induced esophageal injury: survey of the literature. Am J Gastroenterol 1987; 82: 758-63.
3. Heller J R, Fellows I W, Ogilvie A L, Atkinson M. Nonsteroidal anti-inflammatory drugs and benign oesophageal stricture. BMJ 1982; 285: 167-8.
4. Collins F J, Matthews H R, Baker S E, Strakova J M. Druginduced oesophageal injury. BMJ 1979; 1: 1673-6.
5. Parfitt J R, Jayakumar S, Driman D K. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol 2008; 1367-72.
6. Loft D E, Stubington S, Clark C, Rees W D W. Oesophageal ulcer caused by warfarin. Postgrad Med J 1989; 65: 258-9.
7. Gulsen M T, Buyukberber N M, Karaca M, Kadayifci A. Cypoterone acetate and ethinylestradiol-induced pill oesophagitis. A case report. Int J Clin Pract Suppl 2005; 147: 79-81.
8. Smith S J, Lee A J, Maddix D S, Chow A W. Pill-induced esophagitis caused by oral rifampin. Ann Pharmacother 1999; 33: 27-31.
9. Adachi W, Watanabe H, Yasawa K et al. A case of pill-induced esophagitis with mucosal dissection. Diagn Ther Endosc 1998; 4: 149-53.
10. Bonavina L, Demeester T R, McChesney R, Schwizer W, Albertucci M, Bailey R T. Drug induced esophageal strictures. Ann Surg 1987; 206: 173-83.
11. Hughes R. Drug-induced oesophageal injury. BMJ 1979; 2: 132.
12. Abbarah T R, Fredell J E, Ellenz G B. Ulceration by oral ferrous sulfate. JAMA 1976; 236: 2320.
13. Mittal R K, Siskind B N, Hongo M, Flye M W, McCallum RW. Dysphagia aortica. Clinical, radiological and manometric findings. Dig Dis Sci 1986; 31: 379-84.
14. Helm J F, Dodds W J, Pelc L R, Palmer D W, Hogan W J, Teeter B C. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 1984; 310: 284-8.
15. Humphries T J, Castell D O. Pressure profile of esophageal peristalsis in normal humans as measured by direct intraesophageal transducers. Am J Dig Dis 1977; 22: 641-5.
16. Fellows I W, Atkinson M, Ogilvie A L. Oesophageal stricture associated with emepronium bromide therapy. BMJ 1982; 58: 43-4.
17. Pilbrant A. Ulceration due to emepronium bromide tablets. Lancet 1977; 1: 749.
18. Lauder A D. Cetiprin and oesophageal ulceration. BMJ 1979; 2: 211.
19. Parfitt J R, Driman D K. Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol 2007; 38: 527-36.
20. Hongo M, Traube M, McCallum R W. Comparison of effects of nifedipine, propantheline bromide and the combination on esophageal motor function in normal volunteers. Dig Dis Sci 1984; 29: 300-4.
21. Crowson T D, Lionel H H, Ferrante W A. Oesophageal ulcers associated with tetracycline therapy. JAMA 1976; 235: 2747-8.
22. Leong R W, Chan F K. Drug-induced side effects affecting the gastrointestinal tract. Expert Opin Drug Saf 2006; 5: 585-92.
23. Fraser GM, Odes H S, Krugliak P. Severe localised esophagitis due to doxycycline. Endoscopy 1987; 19: 86.
24. Teplick J G, Teplick S K, Ominsky S H, Haskin M E. Esophagitis caused by oral medication. Radiology 1980; 134: 23-5.
25. Lambert J R, Newman A. Ulceration and stricture of the esophagus due to oral potassium chloride therapy. Am J Gastroenterol 1980; 73: 508-11.
26. Allen A C, Boley S J, Schultz L, Schwartz S. Potassiuminduced lesions of the small bowel. JAMA 1965; 193: 1001-6.
27. Rosental T, Adar R, Militianu J, Deutsch V. Esophageal ulceration and oral potassium chloride ingestion. Chest 1974; 65: 463-5.
28. Carlborg B. Biverkningar vid accidental losning av lakemedel I esofagus ah bronker. Lakartidningen 1976; 73: 4201-4.
29. Evans K T, Roberts G M. Where do all the tablets go? Lancet 1976; 4: 1237-9.
30. Geagea A, Cellier C. Scope of drug-induced, infectious and allergic esophageal injury. Curr Opin Gastroenterol 2008; 24: 496-501.
31. McCall A J. Slow-K ulceration of oesophagus with aneurysmal left atrium. BMJ 1975; 3: 230-1.
32. Peters J L. Benign oesophageal stricture following oral potassium chloride therapy. Br J Surg 1976; 63: 698-9.
33. de Groen P C, Lubbe D F, Hirsch L J et al. Esophagitis associated with the use of alendronate. N Engl J Med 1996; 335: 1016-21.
34. Black D M, Cummings S R, Karpf D B et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348: 1535-41.
35. Lanza F, Sahba B, Schwartz H et al. The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study. Am J Gastroenterol 2002; 97: 58-64.
36. Taggart H, Bolognese M A, Lindsay R et al. Upper gastrointestinal tract safety of risedronate: a pooled anaylysis of 9 clincial trials. Mayo Clin Proc 2002; 77: 262-70.
37. Lanza F L, Hunt R H, Thomson A B, Provenja J M, Blank M A. Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. Gastroenterology 2000; 119: 631-8.
38. Strampel W, Emkey R, Civitelli R. Safety considerations with biphosphonates for the treatment of osteoporosis. Drug Saf 2007; 30: 755-63.
39. Safaie-Shirazi S S, Zike W L, Brubacher M, DenBesten L. Effect of aspirin alcohol and pepsin on mucosal permeability of esophageal mucosa. Surg Forum 1974; 25: 335-7.
40. Kim S L, Hunter J G, Wo JM, Dvis L P, Waring J P. NSAIDs, aspirin and esophageal strictures: are over-the-counter mediations harmful to the esophagus? J Clin Gastroenterol 1999; 29: 32-4.
41. Netzer P, Gschossmann J M, Staumann A, Sendesky A, Weiman R, Schoepfer A M. Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol 2007: 865-9.
42. Williams J G. Drug-induced oesophageal injury. BMJ 1979; 2: 273.
43. Parfitt J R, Jayakumar S, Driman D K. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol 2008; 32: 1367-72.
44. Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf 2000; 22: 237-49.
45. Howie A D, Strachan R W. Slow release potassium chloride treatment. BMJ 1975; 2: 176.
46. Abid S, Mumtaz K, Jafri W et al. Pill-induced esophageal injury: endoscopic features and clinical outcome. Endoscopy 2005; 37: 740-4.
47. Amendola M A, Spera T D. Doxycycline induced esophagitis. JAMA 1985; 253: 1009-11.
48. Creteur V, Laufer I, Kressel H Y et al. Drug-induced esophagitis detected by double-contrast radiography. Radiology 1983; 147: 365-8.